It was reported on November 27, that Michael J Farrell, Chief Executive Officer at ResMed RMD executed a significant insider ...

What Happened: In a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday, Farrell, Chief Executive Officer at ResMed, acquired stock options for 33,036 shares of RMD. These ...

Fisher & Paykel is well-positioned to benefit from long-term growth prospects in hospital and home respiratory care. Increasing adoption of nasal high flow, or NHF, therapy in the hospital division is ...

ASX: RESMED INC - RMD Elliott Elliott Wave Technical ... EUR/USD resumed its widespread leg lower on Tuesday, rapidly setting aside Monday’s bullish price action and returning to the area ...

The Australian sharemarket has taken a sharp tumble on Friday morning, after setting another record high on Thursday.

VVeno Medical's NVNO submission of the final module for VenoValve’s Premarket Approval (PMA) application to the FDA represents a crucial milestone in addressing unmet needs in the treatment of Chronic ...

They are focused on developing innovative products that cater to various healthcare settings, such as hospitals ... Masimo ...

Analyzing ResMed Inc.'s Q1 2025 results, stock performance, and sentiment to determine if further upside or profit taking is ...

ResMed shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82. Warren Buffett Owns 6 High-Yield Dividend Stocks. Here's the Best of the Bunch ...

ResMed (RMD) is on the list of such stocks currently recommended by our proprietary system. In addition to a favorable Growth Score, it carries a top Zacks Rank. Research shows that stocks ...

Learn More Healthcare stock ResMed Inc (ASX: RMD) remains a popular investment for Australian investors in 2024. And for good reason. This company is now sitting on a year-to-date gain of more ...